Sesquisabinene hydrate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: Sesquisabinene hydrate
• 英文别名: 2-methyl-5-(6-methylhept-5-en-2-yl)bicyclo[3.1.0]hexan-2-ol
• 化学式: C₁₅H₂₆O
• 分子量: 222.37
• InChiKey: IRDFGGRWKUKANK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• NOVEL PHARMACEUTICALS, DIETARY SUPPLEMENTS AND COSMETIC COMPOSITIONS, AND THE USE OF CERTAIN MIXTURES FOR PREPARING A MEDICAMENT OR A DIETARY SUPPLEMENT FOR THE TREATMENT OR PREVENTION OF INFLAMMATION, HYPERSENSITIVITY REACTIONS OR PAIN
  申请人：Ida Royalty APS

  公开号：EP1156814A2

  公开（公告）日：2001-11-28
• EP3752624A1
  申请人：——

  公开号：EP3752624A1

  公开（公告）日：2020-12-23
• DIAGNOSIS AND TREATMENT OF FUSARIOSIS AND SCEDOSPORIOSIS
  申请人：The Brigham and Women's Hospital, Inc.

  公开号：US20200041484A1

  公开（公告）日：2020-02-06

  Methods for diagnosing, treating, and monitoring the treatment of fusariosis or scedosporiosis are described. The methods can include detecting the presence of one or more volatile organic compounds (VOCs) in the breath of subjects suspected of having fusariosis or scedosporiosis.
• CHIMERIC TERPENE SYNTHASES
  申请人：Ginkgo Bioworks, Inc.

  公开号：US20210147880A1

  公开（公告）日：2021-05-20

  Described herein are chimeric terpene synthases, methods for making chimeric terpene synthases, and methods for making terpenes using the same.
• [EN] NOVEL PHARMACEUTICALS, DIETARY SUPPLEMENTS AND COSMETIC COMPOSITIONS, AND THE USE OF CERTAIN MIXTURES FOR PREPARING A MEDICAMENT OR A DIETARY SUPPLEMENT FOR THE TREATMENT OR PREVENTION OF INFLAMMATION, HYPERSENSITIVITY REACTIONS OR PAIN<br/>[FR] NOUVEAUX PRODUITS PHARMACEUTIQUES, SUPPLEMENTS ALIMENTAIRES ET COMPOSITIONS COSMETIQUES, ET UTILISATION DE CERTAINS MELANGES POUR PREPARER UN MEDICAMENT OU UN SUPPLEMENT ALIMENTAIRE AFIN DE TRAITER OU DE PREVENIR UNE INFLAMMATION, DES REACTIONS D'HYPERSENSIBILITE OU UNE DOULEUR
  申请人：IDA DEVELOPMENTS A S

  公开号：WO2000051576A2

  公开（公告）日：2000-09-08

  The present invention relates to mixtures comprising at least one of the fatty acids eicosapentaenoic acid (20:5n3) and docosahexaenoic acid (22:6n3) and the plant Zingiber officinale Roscoe or parts thereof or an extract or a component thereof as novel pharmaceuticals, dietary supplements or cosmetic compositions containing such mixtures, and to the use of such mixtures for preparing a medicament or a dietary supplement for the suppression of hypersensitivity and/or inflammatory reaction.